SANTEN Trademark

Trademark Overview


On Friday, February 16, 2018, a trademark application was filed for SANTEN with the United States Patent and Trademark Office. The USPTO has given the SANTEN trademark a serial number of 79228774. The federal status of this trademark filing is REGISTERED as of Tuesday, April 23, 2019. This trademark is owned by Santen Pharmaceutical Co., Ltd.. The SANTEN trademark is filed in the Pharmaceutical Products category with the following description:

Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for treatment of eye disease; pharmaceutical preparations for use in eye injections; pharmaceutical preparations for treatment of pinguecula; pharmaceurical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive medical plasters; ...
santen

General Information


Serial Number79228774
Word MarkSANTEN
Filing DateFriday, February 16, 2018
Status700 - REGISTERED
Status DateTuesday, April 23, 2019
Registration Number5730380
Registration DateTuesday, April 23, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 5, 2019

Trademark Statements


Goods and ServicesCollyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for treatment of eye disease; pharmaceutical preparations for use in eye injections; pharmaceutical preparations for treatment of pinguecula; pharmaceurical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; antiseptic liquid bandages; breast- nursing pads; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; food for babies; dietary supplements for animals; dental cements; materials for dental fillings and dental prostheses; dental waxes; disposable diapers for incontinence; mothproofing paper; lactose for pharmaceutical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanten Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka-fu 533-8651
JP

Party NameSanten Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka-fu 533-8651
JP

Trademark Events


Event DateEvent Description
Friday, May 1, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, August 30, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 14, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, August 14, 2019FINAL DISPOSITION PROCESSED
Tuesday, July 23, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 23, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, February 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 5, 2019PUBLISHED FOR OPPOSITION
Friday, February 1, 2019NOTIFICATION PROCESSED BY IB
Wednesday, January 16, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 16, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 16, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 29, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 7, 2018ASSIGNED TO LIE
Tuesday, December 4, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 7, 2018CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, July 13, 2018REFUSAL PROCESSED BY IB
Friday, July 13, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Monday, June 18, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 18, 2018REFUSAL PROCESSED BY MPU
Saturday, June 9, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 8, 2018NON-FINAL ACTION WRITTEN
Friday, June 1, 2018ASSIGNED TO EXAMINER
Friday, March 23, 2018APPLICATION FILING RECEIPT MAILED
Monday, March 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 16, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 15, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB